OpenArc Corporate Advisory’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Sell
2,675
-42
-2% -$3.68K ﹤0.01% 704
2026
Q1
$246K Buy
2,717
+323
+13% +$29.6K ﹤0.01% 618
2025
Q4
$215K Buy
+2,394
New +$227K ﹤0.01% 596

Other funds holding ZBH

OpenArc Corporate Advisory's ZBH Position: Q2 2026 in Review

OpenArc Corporate Advisory reduced its Zimmer Biomet (ZBH) stake by 1.5% in Q2 2026, selling an estimated $3.68K and leaving 2,675 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #704.

OpenArc Corporate Advisory first reported a position in ZBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $246K in Q1 2026. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • OpenArc Corporate Advisory held 2,675 shares of Zimmer Biomet worth $230K as of Q2 2026.
  • OpenArc Corporate Advisory sold 42 Zimmer Biomet shares in Q2 2026, an estimated $3.68K.
  • Zimmer Biomet made up ﹤0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #704 holding.
  • OpenArc Corporate Advisory first reported a position in Zimmer Biomet in Q4 2025 and has held it in 3 quarters since.
  • OpenArc Corporate Advisory's Zimmer Biomet position peaked at $246K in Q1 2026.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.